Pancreatic cancer, cystic neoplasms, and endocrine tumors: diagnosis and management | ПРЕЦИЗИОННАЯ ОНКОЛОГИЯ

Pancreatic cancer, cystic neoplasms, and endocrine tumors: diagnosis and management (2015)

%d0%b1%d0%bb%d0%be%d0%ba%d0%bd%d0%be%d1%82

CREATE YOUR OWN POST

You need to register on site.  Post will be published after being moderated

Рак, кистозные неоплазмы и эндокринные опухоли панкреаз: диагноз и лечение (2015)

_pancreatic-cancer-cystic-neoplasms-and-endocrine-tumors_-diagnosis-and-management-wiley-blackwell-2015-%d0%be%d0%b1%d0%bb%d0%be%d0%b6%d0%ba%d0%b0

First Edition

Edited by Hans G. Beger, Akimasa Nakao, John P. Neoptolemos, Shu You Peng, and Michael G. Sarr.

John Wiley & Sons (2015)

ISBN 978-0-470-67318-8


PART I: Ductal adenocarcinoma of the pancreas »

  1. Histologic classification and tumor staging of pancreatic cancer
  2. What we know about carcinogenesis of ductal adenocarcinoma of the pancreas
  3. Familial cancer of the pancreas
  4. Clinical, laboratory, and radiologic presentation of pancreatic cancer
  5. Standards of oncologic pancreatic surgery
  6. Extended resection for pancreatic cancer: risks and benefits
  7. Risk/benefit of total pancreatectomy for pancreatic cancer: are there indications?
  8. Is there a benefit from additional arterial resection of ductal cancer of the pancreas?
  9. Who benefits from ultraradical pancreatic cancer resection?
  10. Risk and results of pancreatic cancer resection
  11. Pancreatic cancer: the role of bypass procedures
  12. Evidence of adjuvant chemotherapy of ductal pancreatic cancer
  13. Neoadjuvant chemotherapy and radiochemotherapy: is there a survival advantage for pancreatic cancer patients?
  14. Standards of palliative chemotherapy and chemoradiotherapy of local advanced pancreatic cancer, side effects, and survival benefits
  15. Management of local and distant recurrence after pancreatic cancer resection
  16. Survival 3, 5, and 10 years after adjuvant regional and neoadjuvant chemotherapy in resectable pancreatic cancer patients: an institutional experience
  17. Nonductal primary malignancies of the pancreas: acinus cell carcinoma
  18. Nonductal primary malignancies of the pancreas: metastatic malignancies

PART II: Periampullary cancers »

  1. Histopathology of tumors of the ampulla of Vater
  2. Clinical approach to periampullary cancer
  3. Adenoma of the papilla of Vater and endoscopic management
  4. Controversies about local or regional treatment of adenoma of the papilla of Vater: the Japanese experience
  5. Cancer of the papilla: surgical management
  6. Evidence of surgical management of distal common bile duct cancer
  7. Evidence of surgical management of duodenal cancer
  8. Survival and chance of cure after surgery, adjuvant chemotherapy, and palliative chemotherapy of periampullary cancers

PART III: Cystic neoplastic lesions of the pancreas »

  1. Histologic classification and staging of cystic neoplastic lesions of the pancreas
  2. Clinical presentation of cystic neoplastic lesions of the pancreas
  3. Endoscopic ultrasonography and cystic fluid analysis of the pancreas: evidence of diagnostic measures
  4. Natural history of IPMN: adenoma–carcinoma sequence in IPMN
  5. What are the pathologic criteria that justified observational management in patients with cystic neoplastic lesions of the pancreas?
  6. Indications for operative intervention of cystic neoplasms of the pancreas
  7. Surgical management of IPMN lesions of the pancreas
  8. Surgical management of mucinous cystic neoplastic lesions of the pancreas
  9. Surgical management of serous cystic neoplasms of the pancreas
  10. Surgical management of solid pseudopapillary neoplasms of the pancreas
  11. Limited oncologic resection or major surgery for cystic neoplasms of the pancreas?
  12. Enucleation of cystic neoplasia of the pancreas, 268
  13. Long-term outcome after observation and surgical treatment of cystic neoplasms of the pancreas

PART IV: Endocrine neoplasms of the pancreas »

  1. Classification of endocrine tumors of the pancreas
  2. Clinical manifestation of endocrine tumors of the pancreas
  3. Evidence of hormonal, laboratory, biochemical, and instrumental diagnostics of endocrine tumors of the pancreas
  4. Evidence of medical and radionuclide-targeted treatment of endocrine tumors of the pancreas
  5. Insulinoma: evidence of surgical treatment
  6. Gastrinoma: evidence of surgical treatment
  7. Rare endocrine tumors of the pancreas: evidence of management
  8. Long-term outcome after clinical management of endocrine tumors of the pancreas

Part V: Chronic pancreatitis with inflammatory tumor of the pancreas »

  1. Chronic pancreatitis with inflammatory mass in the pancreatic head
  2. Chronic tropical pancreatitis: clinical syndromes, natural course management principles
  3. Laboratory, endoscopic, and radiologic diagnostics of chronic pancreatitis with inflammatory mass in the head
  4. Autoimmune pancreatitis: how to recognize this entity and avoid surgical treatment
  5. What is the place of interventional endoscopic treatment in chronic pancreatitis with inflammatory tumor of the pancreatic head?
  6. When to change from conservative to surgical management in alcoholic chronic and tropical chronic pancreatitis
  7. Duodenum-preserving pancreatic head resection in chronic pancreatitis with inflammatory mass
  8. Major resection for chronic pancreatitis
  9. Short-term and long-term outcome after interventional and surgical treatment of chronic pancreatitis with inflammatory mass

Download:


Текст защищен. Пожалуйста, введите логин и паспорт или зарегистрируйтесь. Enter your username and password to gain access to this review.
:
:

 

0